1462950-10-2 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
Methyl 7-(5-fluoro-2-methoxyphenyl)-2-(methylsulfonyl)thieno[3,2-d]pyrimidine-6-carboxylate is used as a research compound for its potential pharmacological properties. It is studied for its possible applications in treating various conditions, such as cancer and inflammatory diseases, due to its unique chemical structure and potential therapeutic effects.
Used in Cancer Treatment:
In the field of oncology, methyl 7-(5-fluoro-2-methoxyphenyl)-2-(methylsulfonyl)thieno[3,2-d]pyrimidine-6-carboxylate is used as a potential anticancer agent. Its specific mechanism of action may vary, but it is believed to target and inhibit the growth of cancer cells, making it a candidate for further research and development in cancer therapies.
Used in Inflammatory Disease Treatment:
Methyl 7-(5-fluoro-2-methoxyphenyl)-2-(methylsulfonyl)thieno[3,2-d]pyrimidine-6-carboxylate is also considered for use in treating inflammatory diseases. Its potential to modulate inflammatory pathways and reduce inflammation makes it a compound of interest for pharmaceutical researchers seeking new treatments for conditions characterized by chronic inflammation.
Check Digit Verification of cas no
The CAS Registry Mumber 1462950-10-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,6,2,9,5 and 0 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1462950-10:
(9*1)+(8*4)+(7*6)+(6*2)+(5*9)+(4*5)+(3*0)+(2*1)+(1*0)=162
162 % 10 = 2
So 1462950-10-2 is a valid CAS Registry Number.
1462950-10-2Relevant academic research and scientific papers
NOVEL THIENOPYRIMIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND THERAPEUTIC USES THEREOF
-
Paragraph 0495; 0509, (2013/10/08)
The present invention relates to compounds of formula (I): wherein R6 is —CONH2 or a —C(Rα)(Rβ)(OH) group; R is a substituted phenyl or heteroaryl group; R7 is an optionally substituted aryl or heteroaryl group. Process for the preparation thereof and therapeutic use thereof.
NOVEL THIENOPYRIMIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND THERAPEUTIC USES THEREOF
-
Page/Page column 87; 88; 92, (2013/10/22)
The present invention relates to compounds of formula (I): wherein R6 is -CONH2 or a -C(Rα)(Rβ)(OH) group; R is a substituted phenyl or heteroaryl group; R7 is an optionally substituted aryl or heteroaryl group. Process for the preparation thereof and therapeutic use thereof.
